221 related articles for article (PubMed ID: 31500643)
1. OPA1: 516 unique variants and 831 patients registered in an updated centralized Variome database.
Le Roux B; Lenaers G; Zanlonghi X; Amati-Bonneau P; Chabrun F; Foulonneau T; Caignard A; Leruez S; Gohier P; Procaccio V; Milea D; den Dunnen JT; Reynier P; Ferré M
Orphanet J Rare Dis; 2019 Sep; 14(1):214. PubMed ID: 31500643
[TBL] [Abstract][Full Text] [Related]
2. Improved locus-specific database for OPA1 mutations allows inclusion of advanced clinical data.
Ferré M; Caignard A; Milea D; Leruez S; Cassereau J; Chevrollier A; Amati-Bonneau P; Verny C; Bonneau D; Procaccio V; Reynier P
Hum Mutat; 2015 Jan; 36(1):20-5. PubMed ID: 25243597
[TBL] [Abstract][Full Text] [Related]
3. First cases of dominant optic atrophy in Saudi Arabia: report of two novel OPA1 mutations.
Galvez-Ruiz A; Neuhaus C; Bergmann C; Bolz H
J Neuroophthalmol; 2013 Dec; 33(4):349-53. PubMed ID: 24051421
[TBL] [Abstract][Full Text] [Related]
4. Autosomal dominant optic atrophy with
Maeda-Katahira A; Nakamura N; Hayashi T; Katagiri S; Shimizu S; Ohde H; Matsunaga T; Kaga K; Nakano T; Kameya S; Matsuura T; Fujinami K; Iwata T; Tsunoda K
Mol Vis; 2019; 25():559-573. PubMed ID: 31673222
[TBL] [Abstract][Full Text] [Related]
5. Mutation survey of the optic atrophy 1 gene in 193 Chinese families with suspected hereditary optic neuropathy.
Chen Y; Jia X; Wang P; Xiao X; Li S; Guo X; Zhang Q
Mol Vis; 2013; 19():292-302. PubMed ID: 23401657
[TBL] [Abstract][Full Text] [Related]
6. Pure and syndromic optic atrophy explained by deep intronic OPA1 mutations and an intralocus modifier.
Bonifert T; Karle KN; Tonagel F; Batra M; Wilhelm C; Theurer Y; Schoenfeld C; Kluba T; Kamenisch Y; Carelli V; Wolf J; Gonzalez MA; Speziani F; Schüle R; Züchner S; Schöls L; Wissinger B; Synofzik M
Brain; 2014 Aug; 137(Pt 8):2164-77. PubMed ID: 24970096
[TBL] [Abstract][Full Text] [Related]
7. OPA1: How much do we know to approach therapy?
Del Dotto V; Fogazza M; Lenaers G; Rugolo M; Carelli V; Zanna C
Pharmacol Res; 2018 May; 131():199-210. PubMed ID: 29454676
[TBL] [Abstract][Full Text] [Related]
8. A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy.
Thiselton DL; Alexander C; Taanman JW; Brooks S; Rosenberg T; Eiberg H; Andreasson S; Van Regemorter N; Munier FL; Moore AT; Bhattacharya SS; Votruba M
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1715-24. PubMed ID: 12036970
[TBL] [Abstract][Full Text] [Related]
9. The prevalence and natural history of dominant optic atrophy due to OPA1 mutations.
Yu-Wai-Man P; Griffiths PG; Burke A; Sellar PW; Clarke MP; Gnanaraj L; Ah-Kine D; Hudson G; Czermin B; Taylor RW; Horvath R; Chinnery PF
Ophthalmology; 2010 Aug; 117(8):1538-46, 1546.e1. PubMed ID: 20417570
[TBL] [Abstract][Full Text] [Related]
10. eOPA1: an online database for OPA1 mutations.
Ferré M; Amati-Bonneau P; Tourmen Y; Malthièry Y; Reynier P
Hum Mutat; 2005 May; 25(5):423-8. PubMed ID: 15832306
[TBL] [Abstract][Full Text] [Related]
11. OPA1 mutations associated with dominant optic atrophy influence optic nerve head size.
Barboni P; Carbonelli M; Savini G; Foscarini B; Parisi V; Valentino ML; Carta A; De Negri A; Sadun F; Zeviani M; Sadun AA; Schimpf S; Wissinger B; Carelli V
Ophthalmology; 2010 Aug; 117(8):1547-53. PubMed ID: 20417568
[TBL] [Abstract][Full Text] [Related]
12. Autophagy controls the pathogenicity of OPA1 mutations in dominant optic atrophy.
Kane MS; Alban J; Desquiret-Dumas V; Gueguen N; Ishak L; Ferre M; Amati-Bonneau P; Procaccio V; Bonneau D; Lenaers G; Reynier P; Chevrollier A
J Cell Mol Med; 2017 Oct; 21(10):2284-2297. PubMed ID: 28378518
[TBL] [Abstract][Full Text] [Related]
13. A novel OPA1 mutation causing variable age of onset autosomal dominant optic atrophy plus in an Australian family.
Ahmad KE; Davis RL; Sue CM
J Neurol; 2015 Oct; 262(10):2323-8. PubMed ID: 26194196
[TBL] [Abstract][Full Text] [Related]
14. A frameshift mutation in exon 28 of the OPA1 gene explains the high prevalence of dominant optic atrophy in the Danish population: evidence for a founder effect.
Thiselton DL; Alexander C; Morris A; Brooks S; Rosenberg T; Eiberg H; Kjer B; Kjer P; Bhattacharya SS; Votruba M
Hum Genet; 2001 Nov; 109(5):498-502. PubMed ID: 11735024
[TBL] [Abstract][Full Text] [Related]
15. OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease.
Delettre C; Lenaers G; Pelloquin L; Belenguer P; Hamel CP
Mol Genet Metab; 2002 Feb; 75(2):97-107. PubMed ID: 11855928
[TBL] [Abstract][Full Text] [Related]
16. OPA1 analysis in an international series of probands with bilateral optic atrophy.
Liskova P; Tesarova M; Dudakova L; Svecova S; Kolarova H; Honzik T; Seto S; Votruba M
Acta Ophthalmol; 2017 Jun; 95(4):363-369. PubMed ID: 27860320
[TBL] [Abstract][Full Text] [Related]
17. Biallelic Optic Atrophy 1 (
Othman BA; Ong JE; Dumitrescu AV
Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741767
[TBL] [Abstract][Full Text] [Related]
18. First submicroscopic inversion of the OPA1 gene identified in dominant optic atrophy - a case report.
Weisschuh N; Mazzola P; Heinrich T; Haack T; Wissinger B; Tonagel F; Kelbsch C
BMC Med Genet; 2020 Nov; 21(1):236. PubMed ID: 33243194
[TBL] [Abstract][Full Text] [Related]
19. Modelling autosomal dominant optic atrophy associated with OPA1 variants in iPSC-derived retinal ganglion cells.
Sladen PE; Jovanovic K; Guarascio R; Ottaviani D; Salsbury G; Novoselova T; Chapple JP; Yu-Wai-Man P; Cheetham ME
Hum Mol Genet; 2022 Oct; 31(20):3478-3493. PubMed ID: 35652445
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of genotype-phenotype analysis of OPA1 mutations in autosomal dominant optic atrophy.
Ham M; Han J; Osann K; Smith M; Kimonis V
Mitochondrion; 2019 May; 46():262-269. PubMed ID: 30165240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
